Gotham Asset Management LLC Invests $639,000 in Diplomat Pharmacy, Inc. (DPLO)

Gotham Asset Management LLC acquired a new stake in Diplomat Pharmacy, Inc. (NYSE:DPLO) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 43,166 shares of the company’s stock, valued at approximately $639,000. Gotham Asset Management LLC owned about 0.06% of Diplomat Pharmacy at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of DPLO. JPMorgan Chase & Co. lifted its stake in shares of Diplomat Pharmacy by 73.1% in the 1st quarter. JPMorgan Chase & Co. now owns 7,235 shares of the company’s stock valued at $116,000 after purchasing an additional 3,056 shares during the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Diplomat Pharmacy by 80.0% in the 2nd quarter. State of Alaska Department of Revenue now owns 8,623 shares of the company’s stock valued at $127,000 after purchasing an additional 3,833 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Diplomat Pharmacy by 46.7% in the 2nd quarter. PNC Financial Services Group Inc. now owns 8,779 shares of the company’s stock valued at $130,000 after purchasing an additional 2,794 shares during the last quarter. BNP Paribas Arbitrage SA lifted its stake in shares of Diplomat Pharmacy by 13.8% in the 1st quarter. BNP Paribas Arbitrage SA now owns 8,876 shares of the company’s stock valued at $142,000 after purchasing an additional 1,073 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan lifted its stake in shares of Diplomat Pharmacy by 4.9% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 10,250 shares of the company’s stock valued at $152,000 after purchasing an additional 480 shares during the last quarter. 69.90% of the stock is owned by institutional investors and hedge funds.

Shares of Diplomat Pharmacy, Inc. (NYSE DPLO) opened at 21.23 on Friday. The stock has a market capitalization of $1.44 billion, a P/E ratio of 116.01 and a beta of 0.74. Diplomat Pharmacy, Inc. has a one year low of $12.25 and a one year high of $29.36. The stock has a 50 day moving average price of $19.96 and a 200 day moving average price of $17.20.

Diplomat Pharmacy (NYSE:DPLO) last released its quarterly earnings data on Monday, August 7th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.10. Diplomat Pharmacy had a return on equity of 7.97% and a net margin of 0.27%. The firm had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.14 billion. During the same period in the prior year, the firm posted $0.23 earnings per share. The firm’s quarterly revenue was up 3.5% on a year-over-year basis. Equities analysts forecast that Diplomat Pharmacy, Inc. will post $0.75 earnings per share for the current year.

Several equities research analysts have recently weighed in on DPLO shares. Zacks Investment Research upgraded Diplomat Pharmacy from a “hold” rating to a “strong-buy” rating and set a $24.00 price target on the stock in a report on Tuesday, October 10th. BidaskClub upgraded Diplomat Pharmacy from a “hold” rating to a “buy” rating in a report on Tuesday, September 26th. Robert W. Baird upgraded Diplomat Pharmacy to a “positive” rating and increased their price target for the stock from $20.00 to $24.00 in a report on Monday, September 18th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $23.75 price target (up from $19.75) on shares of Diplomat Pharmacy in a report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Diplomat Pharmacy currently has an average rating of “Hold” and a consensus price target of $19.69.

WARNING: “Gotham Asset Management LLC Invests $639,000 in Diplomat Pharmacy, Inc. (DPLO)” was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of

Several other large investors also recently bought and sold shares of DPLO. JPMorgan Chase & Co. lifted its stake in shares of Diplomat Pharmacy by 73.1% in the 1st quarter. JPMorgan Chase & Co. now owns 7,235 shares of the company’s stock valued at $116,000 after purchasing an additional 3,056 shares during the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Diplomat Pharmacy by 80.0% in the 2nd quarter. State of Alaska Department of Revenue now owns 8,623 shares of the company’s stock valued at $127,000 after purchasing an additional 3,833 shares during the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Diplomat Pharmacy by 46.7% in the 2nd quarter. PNC Financial Services Group Inc. now owns 8,779 shares of the company’s stock valued at $130,000 after purchasing an additional 2,794 shares during the last quarter. BNP Paribas Arbitrage SA lifted its stake in shares of Diplomat Pharmacy by 13.8% in the 1st quarter. BNP Paribas Arbitrage SA now owns 8,876 shares of the company’s stock valued at $142,000 after purchasing an additional 1,073 shares during the last quarter. Finally, Municipal Employees Retirement System of Michigan lifted its stake in shares of Diplomat Pharmacy by 4.9% in the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 10,250 shares of the company’s stock valued at $152,000 after purchasing an additional 480 shares during the last quarter. 69.90% of the stock is owned by institutional investors and hedge funds.

Shares of Diplomat Pharmacy, Inc. (NYSE DPLO) opened at 21.23 on Friday. The stock has a market capitalization of $1.44 billion, a P/E ratio of 116.01 and a beta of 0.74. Diplomat Pharmacy, Inc. has a one year low of $12.25 and a one year high of $29.36. The stock has a 50 day moving average price of $19.96 and a 200 day moving average price of $17.20.

Diplomat Pharmacy (NYSE:DPLO) last released its quarterly earnings data on Monday, August 7th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.10. Diplomat Pharmacy had a return on equity of 7.97% and a net margin of 0.27%. The firm had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.14 billion. During the same period in the prior year, the firm posted $0.23 earnings per share. The firm’s quarterly revenue was up 3.5% on a year-over-year basis. Equities analysts forecast that Diplomat Pharmacy, Inc. will post $0.75 earnings per share for the current year.

Several equities research analysts have recently weighed in on DPLO shares. Zacks Investment Research upgraded Diplomat Pharmacy from a “hold” rating to a “strong-buy” rating and set a $24.00 price target on the stock in a report on Tuesday, October 10th. BidaskClub upgraded Diplomat Pharmacy from a “hold” rating to a “buy” rating in a report on Tuesday, September 26th. Robert W. Baird upgraded Diplomat Pharmacy to a “positive” rating and increased their price target for the stock from $20.00 to $24.00 in a report on Monday, September 18th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $23.75 price target (up from $19.75) on shares of Diplomat Pharmacy in a report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Diplomat Pharmacy currently has an average rating of “Hold” and a consensus price target of $19.69.

WARNING: “Gotham Asset Management LLC Invests $639,000 in Diplomat Pharmacy, Inc. (DPLO)” was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The legal version of this piece can be viewed at https://ledgergazette.com/2017/10/20/gotham-asset-management-llc-invests-639000-in-diplomat-pharmacy-inc-dplo.html.

Diplomat Pharmacy Profile

Diplomat Pharmacy, Inc (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company’s primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialty infusion therapy, and various other serious and/or long-term conditions.

Want to see what other hedge funds are holding DPLO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Diplomat Pharmacy, Inc. (NYSE:DPLO).

Institutional Ownership by Quarter for Diplomat Pharmacy (NYSE:DPLO)

Receive News & Ratings for Diplomat Pharmacy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diplomat Pharmacy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply